Industry Research Reports

Home > Reports > Chemical & Material > β-Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

β-Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Chemical & Material

Published Date: 2024-01-18

Pages: 104 Pages

Report ld: 2323014

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

β-Nicotinamide Mononucleotide (NMN) Market Size(US$)

CAGR 2024-2030

12.6%

Market Size,2030

USD 707.1

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 346.9 million

Market Forecast in 2030(Value)

US$ 707.1 million

CAGR

12.6%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

ß-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 297.5 million in 2023 and is forecast to a readjusted size of US$ 707.1 million by 2030 with a CAGR of 12.6% during the forecast period 2024-2030

Global key players of β-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.

MARKET SEGMENTATION

By Company

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Content Greater than or Equal to 98%
Content Less than 98%

Segment by Application

Health Care Products
Cosmetics
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for β-Nicotinamide Mononucleotide (NMN), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of β-Nicotinamide Mononucleotide (NMN) by region & country, by Type, and by Application.

The β-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Nicotinamide Mononucleotide (NMN).

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of β-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of β-Nicotinamide Mononucleotide (NMN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of β-Nicotinamide Mononucleotide (NMN) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 β-Nicotinamide Mononucleotide (NMN) Product Introduction

1.2 Global β-Nicotinamide Mononucleotide (NMN) Market Size Forecast

1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030)

1.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume (2019-2030)

1.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Price (2019-2030)

1.3 β-Nicotinamide Mononucleotide (NMN) Market Trends & Drivers

1.3.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends

1.3.2 β-Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunity

1.3.3 β-Nicotinamide Mononucleotide (NMN) Market Challenges

1.3.4 β-Nicotinamide Mononucleotide (NMN) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global β-Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2023)

2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024)

2.3 Global β-Nicotinamide Mononucleotide (NMN) Players Sales Volume Ranking (2023)

2.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Company Players (2019-2024)

2.5 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Company (2019-2024)

2.6 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of β-Nicotinamide Mononucleotide (NMN)

2.9 β-Nicotinamide Mononucleotide (NMN) Market Competitive Analysis

2.9.1 β-Nicotinamide Mononucleotide (NMN) Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by β-Nicotinamide Mononucleotide (NMN) Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Nicotinamide Mononucleotide (NMN) as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Content Greater than or Equal to 98%

3.1.2 Content Less than 98%

3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type

3.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Type (2019-2030)

3.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Type (%) (2019-2030)

3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type

3.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (2019-2030)

3.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (%) (2019-2030)

3.4 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Health Care Products

4.1.2 Cosmetics

4.1.3 Others

4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application

4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Application (2019-2030)

4.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Application (%) (2019-2030)

4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application

4.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (2019-2030)

4.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (%) (2019-2030)

4.4 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region

5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2019-2024)

5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2025-2030)

5.1.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), (2019-2030)

5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region

5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2019-2024)

5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2025-2030)

5.2.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), (2019-2030)

5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

5.4.2 North America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

5.5.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

5.6.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

5.7.2 South America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

5.8.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value

6.2.1 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.2.2 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Volume, 2019-2030

6.3 United States

6.3.1 United States β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.3.2 United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.4.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.5.2 China β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.5.3 China β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.6.2 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.7.2 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.8.2 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019-2030

6.9.2 India β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

6.9.3 India β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GeneHarbor

7.1.1 GeneHarbor Company Information

7.1.2 GeneHarbor Introduction and Business Overview

7.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.1.5 GeneHarbor Recent Development

7.2 Herbalmax

7.2.1 Herbalmax Company Information

7.2.2 Herbalmax Introduction and Business Overview

7.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.2.5 Herbalmax Recent Development

7.3 Genex Formulas

7.3.1 Genex Formulas Company Information

7.3.2 Genex Formulas Introduction and Business Overview

7.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.3.5 Genex Formulas Recent Development

7.4 Shinkowa Pharmaceutical

7.4.1 Shinkowa Pharmaceutical Company Information

7.4.2 Shinkowa Pharmaceutical Introduction and Business Overview

7.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.4.5 Shinkowa Pharmaceutical Recent Development

7.5 Maac10 Formulas

7.5.1 Maac10 Formulas Company Information

7.5.2 Maac10 Formulas Introduction and Business Overview

7.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.5.5 Maac10 Formulas Recent Development

7.6 EffePharm

7.6.1 EffePharm Company Information

7.6.2 EffePharm Introduction and Business Overview

7.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.6.5 EffePharm Recent Development

7.7 Bontac

7.7.1 Bontac Company Information

7.7.2 Bontac Introduction and Business Overview

7.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.7.5 Bontac Recent Development

7.8 CELFULL

7.8.1 CELFULL Company Information

7.8.2 CELFULL Introduction and Business Overview

7.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.8.5 CELFULL Recent Development

7.9 Kingdomway

7.9.1 Kingdomway Company Information

7.9.2 Kingdomway Introduction and Business Overview

7.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Offerings

7.9.5 Kingdomway Recent Development

8 Industry Chain Analysis

8.1 β-Nicotinamide Mononucleotide (NMN) Industrial Chain

8.2 β-Nicotinamide Mononucleotide (NMN) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 β-Nicotinamide Mononucleotide (NMN) Sales Model

8.5.2 Sales Channel

8.5.3 β-Nicotinamide Mononucleotide (NMN) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. β-Nicotinamide Mononucleotide (NMN) Market Trends

Table 2. β-Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunity

Table 3. β-Nicotinamide Mononucleotide (NMN) Market Challenges

Table 4. β-Nicotinamide Mononucleotide (NMN) Market Restraints

Table 5. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)

Table 7. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Company (2019-2024) & (Kg)

Table 8. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market β-Nicotinamide Mononucleotide (NMN) Price by Company (2019-2024) & (US$/Kg)

Table 10. Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of β-Nicotinamide Mononucleotide (NMN)

Table 13. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Nicotinamide Mononucleotide (NMN) as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)

Table 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2019-2024) & (Kg)

Table 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2025-2030) & (Kg)

Table 24. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2019-2024) & (US$/Kg)

Table 27. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2025-2030) & (US$/Kg)

Table 28. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)

Table 34. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2019-2024) & (Kg)

Table 35. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2025-2030) & (Kg)

Table 36. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2024) & (US$/Kg)

Table 39. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2025-2030) & (US$/Kg)

Table 40. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2019-2024) & (%)

Table 44. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2025-2030) & (%)

Table 45. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (Kg): 2019 VS 2023 VS 2030

Table 46. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2019-2024) & (Kg)

Table 47. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2025-2030) & (Kg)

Table 48. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2019-2024) & (%)

Table 49. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2025-2030) & (%)

Table 50. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2024) & (US$/Kg)

Table 51. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2025-2030) & (US$/Kg)

Table 52. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Volume, (2019-2024) & (Kg)

Table 56. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Volume, (2025-2030) & (Kg)

Table 57. GeneHarbor Company Information

Table 58. GeneHarbor Introduction and Business Overview

Table 59. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 60. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 61. GeneHarbor Recent Development

Table 62. Herbalmax Company Information

Table 63. Herbalmax Introduction and Business Overview

Table 64. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 65. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 66. Herbalmax Recent Development

Table 67. Genex Formulas Company Information

Table 68. Genex Formulas Introduction and Business Overview

Table 69. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 70. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 71. Genex Formulas Recent Development

Table 72. Shinkowa Pharmaceutical Company Information

Table 73. Shinkowa Pharmaceutical Introduction and Business Overview

Table 74. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 75. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 76. Shinkowa Pharmaceutical Recent Development

Table 77. Maac10 Formulas Company Information

Table 78. Maac10 Formulas Introduction and Business Overview

Table 79. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 80. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 81. Maac10 Formulas Recent Development

Table 82. EffePharm Company Information

Table 83. EffePharm Introduction and Business Overview

Table 84. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 85. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 86. EffePharm Recent Development

Table 87. Bontac Company Information

Table 88. Bontac Introduction and Business Overview

Table 89. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 90. Bontac β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 91. Bontac Recent Development

Table 92. CELFULL Company Information

Table 93. CELFULL Introduction and Business Overview

Table 94. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 95. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 96. CELFULL Recent Development

Table 97. Kingdomway Company Information

Table 98. Kingdomway Introduction and Business Overview

Table 99. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 100. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Offerings

Table 101. Kingdomway Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. β-Nicotinamide Mononucleotide (NMN) Downstream Customers

Table 105. β-Nicotinamide Mononucleotide (NMN) Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Picture

Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030) & (US$ Million)

Figure 4. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume (2019-2030) & (Kg)

Figure 5. Global β-Nicotinamide Mononucleotide (NMN) Sales Price (2019-2030) & (US$/Kg)

Figure 6. β-Nicotinamide Mononucleotide (NMN) Report Years Considered

Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global β-Nicotinamide Mononucleotide (NMN) Players Sales Volume Ranking (2023) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by β-Nicotinamide Mononucleotide (NMN) Revenue in 2023

Figure 10. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Content Greater than or Equal to 98% Picture

Figure 12. Content Less than 98% Picture

Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)

Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2019-2030) & (US$/Kg)

Figure 18. Product Picture of Health Care Products

Figure 19. Product Picture of Cosmetics

Figure 20. Product Picture of Others

Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)

Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030) & (US$/Kg)

Figure 26. North America β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030) & (US$ Million)

Figure 27. North America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

Figure 32. South America β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030) & (US$ Million)

Figure 33. South America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Volume (%), (2019-2030)

Figure 38. United States β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 40. United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 44. China β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 45. China β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 46. China β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 56. India β-Nicotinamide Mononucleotide (NMN) Sales Value, (2019-2030) & (US$ Million)

Figure 57. India β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2023 VS 2030

Figure 58. India β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2023 VS 2030

Figure 59. β-Nicotinamide Mononucleotide (NMN) Industrial Chain

Figure 60. β-Nicotinamide Mononucleotide (NMN) Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of β-Nicotinamide Mononucleotide (NMN) in 2030? zhanKai

The global market size of β-Nicotinamide Mononucleotide (NMN) in 2030 was 707.1 Million USD.

What is the annual compound growth rate of the global β-Nicotinamide Mononucleotide (NMN) market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of β-Nicotinamide Mononucleotide (NMN) in 2024? shouQi

Which companies rank high in the global β-Nicotinamide Mononucleotide (NMN) market? shouQi

Related Reports

Global β-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global β-Nicotinamide Mononucleotide (NMN) market size was US$ 468 million in 2025 and is forecast to reach a readjusted size of US$ 1112 million by 2032 with a CAGR of 13.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 76
USD 4250.00
(Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2026
The global β-Nicotinamide Mononucleotide (NMN) market was valued at US$ 468 million in 2025 and is anticipated to reach US$ 1112 million by 2032, at a CAGR of 13.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 135
USD 2900.00
(Single User License)
β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 468 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 13.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 109
USD 3950.00
(Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global β-Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 79
USD 4250.00
(Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global β-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 141
USD 4900.00
(Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published Date: 2025-02-09
Pages: 94
USD 2900.00
(Single User License)
β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 94
USD 3950.00
(Single User License)
Global and China β-Nicotinamide Mononucleotide (NMN) Market Report & Forecast 2024-2030
The global β-Nicotinamide Mononucleotide (NMN) revenue was US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the review period (2024-2030).
Published Date: 2024-12-20
Pages: 102
USD 4350.00
(Single User License)
β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the forecast period 2024-2030.
Published Date: 2024-12-20
Pages: 101
USD 3950.00
(Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global β-Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published Date: 2024-12-20
Pages: 131
USD 4900.00
(Single User License)

Global β-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global β-Nicotinamide Mononucleotide (NMN) market size was US$ 468 million in 2025 and is forecast to reach a readjusted size of US$ 1112 million by 2032 with a CAGR of 13.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 76
USD 4250.00 (Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2026
The global β-Nicotinamide Mononucleotide (NMN) market was valued at US$ 468 million in 2025 and is anticipated to reach US$ 1112 million by 2032, at a CAGR of 13.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 135
USD 2900.00 (Single User License)
β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 468 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 13.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 109
USD 3950.00 (Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global β-Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 79
USD 4250.00 (Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global β-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 141
USD 4900.00 (Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published: 2025-02-09
Pages: 94
USD 2900.00 (Single User License)
β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 94
USD 3950.00 (Single User License)
Global and China β-Nicotinamide Mononucleotide (NMN) Market Report & Forecast 2024-2030
The global β-Nicotinamide Mononucleotide (NMN) revenue was US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the review period (2024-2030).
Published: 2024-12-20
Pages: 102
USD 4350.00 (Single User License)
β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the forecast period 2024-2030.
Published: 2024-12-20
Pages: 101
USD 3950.00 (Single User License)
Global β-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global β-Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published: 2024-12-20
Pages: 131
USD 4900.00 (Single User License)